LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

Pascal Lamy, former European Commissioner for Trade, and Shona Murray, journalist at Euronews, for The Europe Conversation.

We saw several innovative uses of AI in the past week, and a bad slip-up in news sharing. A quick round-up: ...

Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...

OpenAI CEO Sam Altman backs Retro Biosciences, a San Francisco-based biotech start-up that wants to extend human lifespan by ...

OpenAI debuted its Operator agent system. It’s just a research preview for now, a start toward the promised land of AI agents ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as ...

Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

The pandemic saw a flurry of investment in biotech startups but the past three years have seen shrinking investments in the ...

The groundbreaking partnership focuses on leveraging AI to unlock advancements in cellular regeneration and anti-ageing ...